Lisa Feng sold $1.4M of ACMR
See remarks at ACM Research, Inc.. 30,000 shares at an average of $48.04, traded Mar 5, 2026, filed Mar 9, 2026.
Score components
- +15RoleOfficer
- +25Trade size$1.4M at market
- +10Share of holdings soldSold 46% of holdings
- +15Cluster6 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-26-008479, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | MOption exercise Class A Common Stock10b5-1 | +15,000 | $4.55 | $68k | 65,001 | Mar 9, 2026 |
| Mar 5, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -8,050 | $49.81 | $401k | 56,951 | Mar 9, 2026 |
| Mar 5, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -6,950 | $50.24 | $349k | 50,001 | Mar 9, 2026 |
| Mar 6, 2026 | MOption exercise Class A Common Stock10b5-1 | +15,000 | $4.55 | $68k | 65,001 | Mar 9, 2026 |
| Mar 6, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -14,800 | $46.07 | $682k | 50,201 | Mar 9, 2026 |
| Mar 6, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -200 | $46.58 | $9,316 | 50,001 | Mar 9, 2026 |
| Mar 5, 2026 | MOption exercise Stock Optionderivative10b5-1 | -15,000 | $0.00 | $0 | 0 | Mar 9, 2026 |
| Mar 6, 2026 | MOption exercise Stock Optionderivative10b5-1 | -15,000 | $0.00 | $0 | 0 | Mar 9, 2026 |
Related signals
Other insiders at ACM Research, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | ACM Research, Inc. | David H Wang See Remarks | $11M 140,000 shares | -16% | |
| 25Weak | ACM Research, Inc. | David H Wang See Remarks | $5.2M 110,000 shares | -13% | |
| 40Moderate | ACM Research, Inc. | Mark McKechnie See Remarks | $4.5M 98,551 shares | -162% | |
| 30Weak | ACM Research, Inc. | Tracy Liu director | $2.9M 60,000 shares | -39% | |
| 27Weak | ACM Research, Inc. | Haiping Dun director | $217k 5,000 shares | -100% | |
| 28Weak | ACM Research, Inc. | Charles C Pappis director | $250k 5,000 shares | -100% | |
| 40Moderate | ACM Research, Inc. | Mark McKechnie See Remarks | $1.1M 31,250 shares | -324% | |
| 25Weak | ACM Research, Inc. | David H Wang See Remarks | $4.4M 130,000 shares | -15% | |
| 40Moderate | ACM Research, Inc. | Fuping Chen See remarks | $4.0M 120,000 shares | -120% | |
| 15Weak | ACM Research, Inc. | Lisa Feng See remarks | $998k 30,000 shares | -46% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.